Please login to the form below

Not currently logged in
Email:
Password:

FCB Health’s Neon attracts new managing director

Mardene Miller will lead the agency with co-managing director Kevin McHale

Mardene Miller

Neon has named Harrison and Star's former president Mardene Miller (pictured above) as its new co-managing director.

Neon, which is located in New York, US, is a full-service agency specialising in multichannel marketing, strategic planning and health literacy.

It has a workforce of around 175 employees and operates under the FCB Health Network umbrella.

Miller will lead the 175-workforce agency alongside Kevin McHale, who is also the creative chief.

He said: “Neon is continuing its upward trajectory into 2019. With this redoubled focus in executive management and our commitment to creativity there is no doubt that we will continue to enjoy double digit growth and continue to offer our full service expertise to all brands in need of strategic, creative and account excellence.”

Neon has most recently secured an account win with ColoGuard, a co-promotion initative with Exact Sciences and Pfizer.

In addition, 2018 saw an influx of several new business wins for the agency, which included AbbVie and Flexion.

Regarding her new role at Neon, Miller said: “I am excited to join this exceptional Network, which is setting the bar for creativity and is spearheaded by such a dynamic leader in Dana Maiman.”

Article by
Gemma Jones

14th February 2019

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...
Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...

Infographics